BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28028557)

  • 1.
    Wang HC; Wang ZM; Wang YB; Chen XH; Cui LL
    Abdom Radiol (NY); 2017 May; 42(5):1415-1423. PubMed ID: 28028557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced diuresis improves the diagnostic accuracy of 18F-FDG PET in abdominopelvic malignancies.
    Kamel EM; Jichlinski P; Prior JO; Meuwly JY; Delaloye JF; Vaucher L; Malterre J; Castaldo S; Leisinger HJ; Delaloye AB
    J Nucl Med; 2006 Nov; 47(11):1803-7. PubMed ID: 17079813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced diuresis and dual-phase F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancers.
    Harkirat S; Anand S; Jacob M
    Indian J Radiol Imaging; 2010 Feb; 20(1):13-9. PubMed ID: 20351986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual phase 18F-fluorodeoxyglucose positron emission tomography/computed tomography with forced diuresis in diagnostic imaging evaluation of bladder cancer.
    Yildirim-Poyraz N; Ozdemir E; Uzun B; Turkolmez S
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):214-21. PubMed ID: 23218514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting primary bladder cancer using delayed (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    Indian J Nucl Med; 2012 Jul; 27(3):145-50. PubMed ID: 23919066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique.
    Nayak B; Dogra PN; Naswa N; Kumar R
    Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):386-93. PubMed ID: 23179944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed
    Xu L; Shi Y; Wang Y; Zhou X; Huang G; Chen R; Liu J
    Contrast Media Mol Imaging; 2020; 2020():3216179. PubMed ID: 33013244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of laxative-augmented contrast medium in the evaluation of colorectal foci at FDG PET.
    Chen YK; Chen JH; Tsui CC; Chou HH; Cheng RH; Chiu JS
    Radiology; 2011 May; 259(2):525-33. PubMed ID: 21406631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of dual-phase (18)F-FDG PET/CT in preoperative staging of bladder cancer].
    Li H; Wu H; Wang Q; Han Y; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):500-3. PubMed ID: 24752096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer].
    Fuster D; Lafuente S; Setoain X; Navales I; Perissinotti A; Pavia J; Paredes P; Lomeña F; Pons F
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):111-6. PubMed ID: 22154291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of delayed-time-point imaging during abdominal and pelvic cancer screening using FDG-PET/CT in the general population.
    Naganawa S; Yoshikawa T; Yasaka K; Maeda E; Hayashi N; Abe O
    Medicine (Baltimore); 2017 Nov; 96(46):e8832. PubMed ID: 29145346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 18F-FDG PET/CT imaging with different dual time 18F-FDG PET/CT with forced diuresis in clinical diagnosis of prostate cancer.
    Yu L; Huang S; Wu S; Yue J; Yin L; Lin Z
    Medicine (Baltimore); 2023 Jan; 102(2):e32331. PubMed ID: 36637950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
    Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
    Ozkan E; Soydal C; Araz M; Kir KM; Ibis E
    Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detectability of residual invasive bladder cancer in delayed
    Higashiyama A; Komori T; Juri H; Inada Y; Azuma H; Narumi Y
    Ann Nucl Med; 2018 Oct; 32(8):561-567. PubMed ID: 30014439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
    Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
    Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
    Sasaki K; Kawasaki H; Sato M; Koyama K; Yoshimi F; Nagai H
    Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Value of (18)F-FDG- PET-CT in the Preoperative Staging of Peritoneal Carcinomatosis from Colorectal Origin.
    De Vos N; Goethals I; Ceelen W
    Acta Chir Belg; 2014; 114(6):370-5. PubMed ID: 26021680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.